Article
Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells.
European journal of pharmacology - 5 Dec 2011
Leve Fernanda, Marcondes Taline Guimarães Corrêa, Bastos Lilian Gonçalves R, Rabello Sarah Vieira, Tanaka Marcelo Neves, Morgado-Díaz José Andrés
Abstract excerpt
Lysophosphatidic acid (LPA) acts as a potent stimulator of tumorigenesis. Cell-cell adhesion disassembly, actin cytoskeletal alterations, and increased migratory potential are initial steps of colorectal cancer progression. However, the role that LPA plays in these events in this cancer type is still unknown. We explored this question by using Caco-2 cells, as colon cancer model, and treatment with LPA or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
